One thousand new patients had mean age 58.4 AE 15.8 with BMI 28.8 AE 6.5. Subjects were mostly white (91.9%) and married (62.4%). Half (49.7%) were sexually active, 34.8% had dyspareunia, and few reported history of abnormal pap smears (26.0%) or sexually transmitted infections (2.1%). DV prevalence was 11.9%. Pelvic Pain was the least common CC (8.6%), but most commonly reported DV (24.4%). Prolapse was the most common CC (36.2%), but had the lowest prevalence of DV (6.1%). DV was reported by 15.2% with Overactive Bladder, 14.4% with Stress Incontinence, and 11.6% with CC of "other." Patients with Pelvic Pain CC were more than twice as likely to report DV compared to all other CCs (OR ¼ 2.690, 95% CI ¼ 1.576-4.592). Those with pelvic pain were more likely to report DV when compared individually to prolapse (OR ¼ 4.993, 95% CI ¼ 2.596-9.604) and "other" (OR ¼ 2.472, 95% CI ¼ 1.282-4.766). There was no statistical difference compared to overactive bladder (OR ¼ 1.798, 95% CI ¼ 0.988-3.271) or stress urinary incontinence (OR ¼ 1.915, 95% CI ¼ 0.905-4.055). Multivariable regression is shown in Table 1 with 5 predictors of DV on both univariable and multivariable logistic regression. After adjustment, CC of pelvic pain was still 1.862 times as likely to report DV. Nocturia was an additional urogynecologic variable predictive of DV (OR ¼ 1.162 per nightly episode, 95% CI ¼ 1.033-1.308). Smoking conferred the highest likelihood of DV (OR ¼ 3.676, 95% CI ¼ 2.252-5.988). CONCLUSION: Domestic violence was experienced by 11.9% of outpatient urogynecology patients. This is lower than reported in the general population, potentially due to reporting bias or the older age of our patients. While those with CC of prolapse were less likely to report DV, we recommend routine screening in all women. Special efforts should be made to screen those at higher risk with CC of pelvic pain who were younger, smokers, with higher BMI, and with increased nocturia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.